Skip to content
SEARCH icon
  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Market News
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Technology
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
icon

      HomeBiotech

      Biotech

      Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735
      Biotech

      Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-1 Trial of VK2735

      November 19, 2025
      Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
      Biotech

      Piramal Pharma Solutions’ Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates

      November 19, 2025
      Amorepacific Named CES Innovation Award Honoree for Advanced Electronic Skin Platform
      Biotech

      Amorepacific Named CES Innovation Award Honoree for Advanced Electronic Skin Platform

      November 15, 2025
      Aquaporin Q3 2025 Trading Statement
      Biotech

      Aquaporin Q3 2025 Trading Statement

      November 13, 2025
      Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan
      Biotech

      Onward Therapeutics Completes Share Exchange and Establishes Global Headquarters in Taiwan

      November 11, 2025
      Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours
      Biotech

      Leucid Bio Provides Update on Phase I/IIa AERIAL Trial Evaluating Lateral CAR-T LEU011 for the Treatment of Solid Tumours

      November 10, 2025
      AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
      Biotech

      AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025

      November 9, 2025
      ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut
      Biotech

      ACAAI 2025 | CS2015 (OX40L/TSLP Bispecific Antibody) Makes International Debut

      November 7, 2025
      Desert Control Releases Q3 2025 Report and Year-to-Date Company Update
      Biotech

      Desert Control Releases Q3 2025 Report and Year-to-Date Company Update

      November 6, 2025
      Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade
      Biotech

      Onassis Holdings Appoints Esq. Paz Itzhaki-Weinberger to Advisory Board to Oversee International Law and Trade

      November 5, 2025
      1 2 3 … 33 »

       

      LATEST NEWS

      • Investing News Verizon Layoffs Impact Over 13,000 Workers Amid Major Shift
      • Investing News PepsiCo’s 2025 Reset: Cost Cuts Meet New Innovation
      • Investing News Uber Ski Service Redefines Winter Travel
      • Investing News Alibaba Qwen AI Upgrade: A New Consumer Push

      UpAlpha

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from UpAlpha.

      I want e-mail alerts, updates, and offers and agree to the UpAlpha privacy policy.

      Market Jar Media Inc. © 2025